Search
AngioDynamics Inc
ANGOAdd to Watchlist
15.280USD
-0.230-1.48%
Close 09-24 16:00（ET）
631.52MMarket Cap
LossP/E TTM
AngioDynamics Inc (ANGO) Stock Price Target & Forecast
Analyst Rating
Based on 4 analysts giving stock ratings to AngioDynamics Inc in the past month.
Buy
0 Strong Buy
4 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
20.000USD+28.95%
ANGO Analyst Recommendation Trends
In the current month, ANGO has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ANGO average Analyst price target in the last month is 20.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
1
1
1
1
1
1
4
4
4
3
3
3
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
5
4
4
4
4
4
ANGO Analyst Rating for Peer Comparison
Updated: Sep 24, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Stryker Corp
SYK
11
13
6
0
0
30
Medtronic PLC
MDT
9
10
11
0
0
30
Dexcom Inc
DXCM
13
13
4
0
0
30
Zimmer Biomet Holdings Inc
ZBH
2
6
21
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Abbott Laboratories
ABT
11
12
5
0
0
28
Insulet Corp
PODD
7
8
12
0
0
27
Guardant Health Inc
GH
12
13
2
0
0
27
Repligen Corp
RGEN
5
14
3
0
0
22
Tandem Diabetes Care Inc
TNDM
4
8
10
0
0
22
Financial Forecasting
Based on analysts' estimates, ANGO EPS is projected to reach -0.113 in FY2027Q1, following reported EPS of -0.273 in FY2026Q4. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
FY2027Q2
Forecast
-0.10
-0.11
-0.09
-0.11
-0.08
Actual
-0.15
-0.19
-0.27
--
--
Surprise
-52.86%
-76.68%
-203.87%
--
--
FAQs
What is AngioDynamics Inc's expected revenue for the next quarter?
AngioDynamics Inc's expected revenue is 80.50M.
What is AngioDynamics Inc's price target?
Analysts forecast that AngioDynamics Inc's price target is USD 20.00, with the highest forecast at USD 24.00 and the lowest forecast at USD 17.00.
How have AngioDynamics IncANGO's recent earnings per share performed?
The market expectation was USD -0.27, while AngioDynamics IncANGO's earnings per share (EPS) for the previous quarter was USD -0.19. EPS for the next quarter is expected at USD -0.11.
What is the analyst rating for AngioDynamics Inc?
Based on the ratings of AngioDynamics Inc's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.